Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21087449 | 0.94 | POLB (0.35) | POLBAPEX1HTTTDP1RARA | |
| SCHEMBL22353022 | 0.92 | POLB (0.37) | POLBAPEX1HTTTDP1RARA | |
| SCHEMBL21693411 | 0.89 | POLB (0.32) | POLBAPEX1HTTTDP1CYP3A4 | |
| SCHEMBL25795370 | 0.86 | POLB (0.37) | POLBAPEX1HTTTDP1RARA | |
| SCHEMBL16559830 | 0.85 | POLB (0.41) | POLBAPEX1HTTTDP1RARA | |
| SCHEMBL18558996 | 0.85 | THRB (0.33) | POLBAPEX1HTTTDP1THRB | |
| SCHEMBL18773630 | 0.85 | THRB (0.33) | POLBAPEX1HTTTDP1THRB | |
| SCHEMBL16559845 | 0.84 | POLB (0.40) | POLBAPEX1HTTTDP1RARA | |
| SCHEMBL21254294 | 0.84 | POLB (0.35) | POLBAPEX1HTTTDP1RARA | |
| SCHEMBL16559831 | 0.83 | POLB (0.39) | POLBAPEX1HTTTDP1RARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892706-A2 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |